GLP-1 Users with Sleep Apnea Had About 40% Lower Acute Respiratory Failure Risk in Early CHEST Data

Sleep apnea patients on GLP-1 drugs had less acute respiratory failure in a nearly 2-million-patient CHEST 2026 analysis. What the data can’t show.

Have A Referral?